Bowel Colon Cancer
Tuesday 13th January 1:30 pm - 4:30 pm
Cancer courses

Targeted treatments and immunotherapy for Bowel Cancer

Virtual delivery via MS Teams

This course describes how bowel cancer comes about, and explains the reasons why some patients might be given treatments such as EGFR-targeted antibodies (cetuximab and panitumumab), angiogenesis inhibitors (bevacizumab and regorafenib), or immune checkpoint inhibitors (pembrolizumab) as part of their treatment.

Sold out! £90.00